Patent ID: 8008301
Filing Date: 2011-08-30
Classification: C07D

Abstract:
1. A compound structurally represented by Formula I or a pharmaceutically acceptable salt thereof wherein: R1, R2, and R3 are independently at each occurrence R4 and R5 are independently at each occurrence R6 is independently at each occurrence R7 and R8 are independently at each occurrence R9 is independently at each occurrence provided the compound is not (3-Fluoro-4′-methanesulfonyl-biphenyl-4yl)-[-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone, or [4-(6-amino-5-hydroxy-pyridin-3-yl) -phenyl]-(2-pyrrolidin-1-ylmethyl-pyrrolidin-1-yl)-methanone.